A budget impact analysis of empagliflozin for heart failure patients with full spectrum of ejection fraction in South Korea

20 May 2023 (14:00 - 14:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Jong-Chan Youn

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail

Total cholesterol decrease associates with higher mortality in chronic heart failure

Doctor M. Rocha (Porto, PT)

Abstract Slides

Presentation thumbnail

Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor

Professor M. Ufnal (Warsaw, PL)

Abstract Slides

Presentation thumbnail

Hypoalbuminemia increases the time to euvolemia in heart failure patients

Doctor I. Fialho (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial

Doctor A. Sharma (Montreal, CA)

Abstract Slides

Presentation thumbnail

Long-acting relaxin (LY3540378) demonstrates improved renal hemodynamics response in preclinical and clinical studies

Doctor X. Wang (Indianapolis, US)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - pharmacotherapy 6

The Event

Event poster

Heart Failure 2023

20 May 2023 14:00 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources